Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Miho Ichida"'
Autor:
Naruhiko Mizuta, Miho Ichida, Hiroo Nakajima, Junji Magae, Ikuya Fujiwara, Asako Nishiyama, Mahiro Ohashi, Yoshimi Umeda, Koichi Sakaguchi
Publikováno v:
World Journal of Surgery. 34:2197-2203
Skin-sparing partial mastectomy (SSPM) has yet to be investigated as a breast-conserving therapy for early-stage breast cancer. We report the clinical outcomes for video-assisted SSPM (VA-SSPM) with immediate breast reconstruction using autogenous ti
Autor:
Hiroo NAKAJIMA, Ikuya FUJIWARA, Koichi SAKAGUCHI, Naruhiko MIZUTA, Yasushi HACHIMINE, Katsuhiko NAKATSUKASA, Miho ICHIDA
Publikováno v:
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 33:1-7
Autor:
Miho Ichida, Naruhiko Mizuta, Koichi Sakaguchi, Akio Yanagisawa, Ikuya Fujiwara, Yasushi Hachimine, Eiichi Konishi, Mahiro Ohashi, Hiroo Nakajima, Katsuhiko Nakatsukasa
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69:1866-1871
Autor:
Miho Ichida, Yasushi Hachimine, Katsuhiko Nakatsukasa, Akio Yanagisawa, Ikuya Fujiwara, Koichi Sakaguchi, Eiichi Konishi, Hiroo Nakajima, Naruhiko Mizuta
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 68:2171-2177
目的 : 乳癌を, エストロゲンレセプター (ER) とHER2発現により分類し, その予後を検討する.対象と方法 : 乳癌手術症例でERとHER2の免疫組織化学染色を行った218例をERの発現の有無と, HER2はHe
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 16(9)
Background: Low-dose oral contraceptives (OC) were approved by the Japanese Ministry of Health, Labor and Welfare in 1999, yet despite their contraceptive and non-contraceptive health benefits, only 5% of the target population use them. Fear of incre
Autor:
Naruhiko, Mizuta, Koichi, Sakaguchi, Mitsuhiko, Mizuta, Miho, Ichida, Mahiro, Ohashi, Yoshimi, Umeda, Asako, Nishiyama, Midori, Matsumoto, Ikuya, Fujiwara
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 37(7)
We report a long-term complete response (CR) in a patient with postoperative recurrent breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid. We administered 4 courses of tri-weekly CE (epirubicin
Autor:
Ruriko Tsushima, Sachiyo Nomura, Rie Kurabayashi, Yasuko Kikuchi, Tomoko Takamaru, Sadako Akashi, Akemi Kataoka, Yuko Ishibashi, Miho Ichida, Reiko Yoshida
Publikováno v:
Annals of Oncology. 25:v54
Background: Clinicopathological features of breast cancer patients with a history of gynecological hormone therapy (OC/HRT) are not clear. Methods: 1) Breast cancer screening results from 2007 to 2012 and 2) breast cancer patients with OC/HRT were an
Autor:
Nakajima, Hiroo, Fujiwara, Ikuya, Mizuta, Naruhiko, Sakaguchi, Koichi, Ohashi, Mahiro, Nishiyama, Asako, Umeda, Yoshimi, Ichida, Miho, Magae, Junji
Publikováno v:
World Journal of Surgery; Sep2010, Vol. 34 Issue 9, p2197-2203, 7p, 2 Color Photographs, 3 Charts